China SXT Pharmaceuticals (SXTC) Current Assets (2018 - 2026)
China SXT Pharmaceuticals (SXTC) posted quarterly Current Assets of $34.5 million for Q1 2026, up 62.04% year-over-year from $21.3 million in Q1 2025, and up 32.51% quarter-over-quarter from $26.0 million in Q3 2025.
China SXT Pharmaceuticals (SXTC) Current Assets (2018 - 2026) Analysis & Trends
China SXT Pharmaceuticals' Current Assets history runs 9 years deep, the most recent figure standing at $34.5 million for Q1 2026.
- In Q1 2026, Current Assets rose 62.04% year-over-year to $34.5 million; the TTM figure through Mar 2026 stood at $34.5 million (up 62.04% YoY), while the FY2026 annual figure was $34.5 million, up 62.04% from the prior year.
- Current Assets for Q1 2026 stood at $34.5 million, up from $26.0 million in the prior quarter.
- The five-year high for Current Assets was $34.5 million in Q1 2026, with the low at $12.4 million in Q3 2022.
- The 5-year median for Current Assets is $21.3 million (2025), against an average of $20.7 million.
- Peak annual rise in Current Assets reached 62.93% in 2024, while the deepest fall reached 27.09% in 2024.
- China SXT Pharmaceuticals' Current Assets stood at $12.4 million in 2022, then climbed by 9.19% to $13.5 million in 2023, then jumped by 62.93% to $22.0 million in 2024, then rose by 18.44% to $26.0 million in 2025, then jumped by 32.51% to $34.5 million in 2026.
- Business Quant data shows SXTC's Current Assets at $34.5 million in Q1 2026, $26.0 million in Q3 2025, and $21.3 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 3.22 Bn |
| 10 | China SXT Pharmaceuticals | 32,029.07 | -28.14 Mn | - | 34.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.51 Mn |
| Sep 30, 2025 | 26.04 Mn |
| Mar 31, 2025 | 21.30 Mn |
| Sep 30, 2024 | 21.99 Mn |
| Mar 31, 2024 | 14.23 Mn |
| Sep 30, 2023 | 13.50 Mn |
| Mar 31, 2023 | 19.52 Mn |
| Sep 30, 2022 | 12.36 Mn |
| Mar 31, 2022 | 22.45 Mn |
| Sep 30, 2021 | 11.66 Mn |
| Mar 31, 2021 | 23.23 Mn |
| Sep 30, 2020 | 22.06 Mn |
| Mar 31, 2020 | 19.64 Mn |
| Sep 30, 2019 | 17.54 Mn |
| Mar 31, 2019 | 15.59 Mn |
| Sep 30, 2018 | 6.55 Mn |
| Mar 31, 2018 | 6.10 Mn |